benzinga12d ago
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Boston Scientific Corporation (NYSE: BSX ) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between July 23, 2025, and February 3, 2026. Find out if you qualify to recover losses . You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Boston Scientific shares fell $16.12 per share, a decline of approximately 17.6%, after the Company disclosed slower than expected U.S. EP market growth and increased competitive pressures on February 4, 2026. The lead plaintiff deadline is May 4, 2026. The Alleged EP Growth Methodology The global electrophysiology market attracted enormous capital investment between 2024 and 2025, with pulse field ablation (PFA) technology positioned as the fastest-growing segment in medical devices. The lawsuit contends that throughout the Class Period, Boston Scientific projected the EP market would sustain 15% long-range growth while repeatedly asserting the Company would "outpace the market" through its FARAPULSE platform and expanding portfolio. Management characterized PFA adoption as accelerating from 50% global ... Full story available on Benzinga.com